Benitec Biopharma is engaged in the development of gene-silencing therapies for the treatment of chronic and life-threatening diseases.
Business Model:
Revenue: $73k
Employees: 11-50
Address: 3940 Trust Way
City: Hayward
State: CA
Zip: 94545
Country: US
Benitec Biopharma is engaged in the development of gene-silencing therapies for the treatment of chronic and life-threatening diseases.
Contact Phone:
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
7/3/2014
Ticker Symbol:
BNTC
Amount Raised:
$14M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2022 | Post-IPO Equity | $16.2M | 9/2022 | Post-IPO Equity | $18M | 8/2015 | IPO | $13.8M |
|
3/2017 | Post-IPO Equity | 1 | $4.1M |
NantCapital NantCapital |
10/2020 | Post-IPO Equity | $11.5M | 4/2021 | Post-IPO Equity | $12.9M | 4/2014 | Post-IPO Equity | $29.5M |
---|
Announced Date | Name | Price |
---|---|---|
10/2012 | Tacere Therapeutics |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|